Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs

• Hoofdauteurs: Veronique Michaud (Auteur), Pamela Dow (Auteur), Sweilem B. Al Rihani (Auteur), Malavika Deodhar (Auteur), Meghan Arwood (Auteur), Brian Cicali (Auteur), Jacques Turgeon (Auteur)
• Formaat: Boek
• Gepubliceerd in: Wiley, 2021-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The risk‐benefit ratio associated with the use of repurposed drugs to treat severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)‐related infectious coronavirus disease 2019 (COVID‐19) is complicated because benefits are awaited, not proven. A thorough literature search was conducted to sourc...